Clinical Trials & Research Studies
Breast cancer clinical trials, also called clinical studies, are a type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis or treatment.
In this section, get basic information about metastatic breast cancer clinical trials, explore whether taking part in a clinical trial is right for you and find studies you may be eligible to participate in.
You can also get information and updates on other breast cancer research studies that follow participants over time to determine treatment outcomes.
A clinical trial seeks 880 participants to test whether removing the tumor in the breast in newly diagnosed metastatic breast cancer helps women who receive systemic therapy to live longer than those who receive systemic therapy alone.
A phase III clinical trial evaluates trastuzumab emtansine (TDM-1), a new type of HER2-targeted therapy, in participants with HER2 positive metastatic breast cancer that stopped responding to treatment.
SWOG-S0500 is a clinical trial studying whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not.